Intermedin attenuates myocardial infarction through activation of autophagy in a rat model of ischemic heart failure via both cAMP and MAPK/ERK1/2 pathways

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 9836-9844

  Wei, Peng ^a   Yang, Xiang Jun ^a   Fu, Qiang ^b   Han, Bing ^b   Ling, Lin ^a   Bai, Jie ^c   Zong, Bin ^b   Jiang, Chun Ying ^b  

^a SOOCHOW UNIVERSITY   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; cAMP; ERK1 2; Intermedin; Ischemic heart failure

Indexed keywords

ADRENOMEDULLIN; CYCLIC AMP; INTERMEDIN PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEUROPEPTIDE;

ANIMAL; AUTOPHAGY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART INFARCTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ADRENOMEDULLIN; ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; CYCLIC AMP; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MYOCARDIAL INFARCTION; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85013041601     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Choi JH, Comess KA, Xu C, Park J and Kim Y. Development of an interactive Coronary Do-ppler Vibrometry system for detection of coronary artery disease. Conf Proc IEEE Eng Med Biol Soc 2011; 2011: 7195-7198.
2. Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C and Zhang Y. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum 2013; 65: 805-814.
3. Bi YF, Mao JY, Wang XL, Hou YZ, Lu YZ, Soh SB and Zhang BL. Clinical epidemiology survey of the traditional Chinese medicine etiology and syndrome differentiation of coronary artery disease: study protocol of a multicenter trial. Zhong Xi Yi Jie He Xue Bao 2012; 10: 619-627.
4. Zhang Q, Xu B, Yang YJ, Zhang RY, Li JP, Qiao SB, Zhang JS, Hu J, Qin XW, Hong T, Chen JL, Huo Y, Shen WF and Gao RL. Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical study. Chin Med J (Engl) 2007; 120: 533-538.
5. Burchill LJ, Lameijer H, Roos-Hesselink JW, Grewal J, Ruys TP, Kulikowski JD, Burchill LA, Oudijk MA, Wald RM, Colman JM, Siu SC, Pieper PG and Silversides CK. Pregnancy risks in women with pre-existing coronary artery disease, or following acute coronary syndrome. Heart 2015; 101: 525-529.
6. Yan GH, Wang M, Yiu KH, Lau CP, Zhi G, Lee SW, Siu CW and Tse HF. Subclinical left ventricular dysfunction revealed by circumferential 2D strain imaging in patients with coronary artery disease and fragmented QRS complex. Heart Rhythm 2012; 9: 928-935.
7. Zhao K, Xu XS, Meng X, Li YL, Li JF and Chen WQ. Autophagy of monocytes attenuates the vulnerability of coronary atherosclerotic pla-ques. Coron Artery Dis 2013; 24: 651-656.
8. Mostafalou S and Abdollahi M. Pesticides and human chronic diseases: evidences, mechanisms, and perspectives. Toxicol Appl Pharma-col 2013; 268: 157-177.
9. Ghavami S, Cunnington RH, Gupta S, Yeganeh B, Filomeno KL, Freed DH, Chen S, Klonisch T, Halayko AJ, Ambrose E, Singal R and Dixon IM. Autophagy is a regulator of TGF-beta1-induced fibrogenesis in primary human atrial myofibroblasts. Cell Death Dis 2015; 6: e1696.
10. Qin L and Crews FT. NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. J Neuroinflammation 2012; 9: 5.
11. Takeuchi M and Saito T. Cytotoxicity of acetaldehyde-derived advanced glycation end-products (AA-AGE) in alcoholic-induced neuronal degeneration. Alcohol Clin Exp Res 2005; 29: 220S-224S.
12. Weiss B. The first 83 and the next 83: perspectives on neurotoxicology. Neurotoxicology 20-09; 30: 832-850.
13. Myers J, London L and Lucchini RG. Neuro-toxicology and development: human, environmental and social impacts. Neurotoxicology 2014; 45: 217-219.
14. Qian J, Xu B, Lansky AJ, Yang YJ, Qiao SB, Wu YJ, Chen J, Hu FH, Yang WX, Mintz GS, Leon MB and Gao RL. First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial. Chin Med J (Engl) 2012; 125: 970-976.
15. Chen WR, Qian YA, Chen YD, Shi Y, Yin da W, Wang H, Zhu P, Liu HW and Sha Y. The effects of low vitamin D on coronary artery disease. Heart Lung Circ 2014; 23: 314-319.
16. Hu CL, Li YB, Tang YH, Chen JB, Liu J, Tang QZ, Zhang QH and Huang CX. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease. Cardiovasc Drugs Ther 2006; 20: 185-191.
17. Li P, Sun HJ, Han Y, Wang JJ, Zhang F, Tang CS and Zhou YB. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats. Peptides 2013; 47: 1-6.
18. Du X, Cao Y, Xue P, Lin Z, Zeng Z and Xia Q. Protective effect of intermedin on myocardial cell in a rat model of severe acute pancreatitis. Cell Mol Biol Lett 2011; 16: 462-476.
19. Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI and Kovalchuk O. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 2010; 127: 1785-1794.
20. Nunes de Carvalho S, Helal-Neto E, de Andrade DC, Costa Cortez EA, Thole AA, Barja-Fidalgo C and de Carvalho L. Bone marrow mononuclear cell transplantation increases metalloproteinase-9 and 13 and decreases tissue inhibitors of metalloproteinase-1 and 2 expression in the liver of cholestatic rats. Cells Tissues Organs 2013; 198: 139-148.
21. Kim B, Abdel-Rahman MH, Wang T, Pouly S, Mahmoud AM and Cebulla CM. Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment. Invest Ophthalmol Vis Sci 2014; 55: 2031-2040.
22. Xiong W, Qiu SY, Xu LY, Zhang CP, Yi Y, Wu Q, Huang LP, Liu SM, Wu B, Peng LC, Song MM, Gao Y and Liang SD. Effects of intermedin on dorsal root ganglia in the transmission of neuropathic pain in chronic constriction injury rats. Clin Exp Pharmacol Physiol 2015; 42: 780-787.
23. Cheng J, Qiao L, Xu X, Zhai C, Zhao K, Ji X and Chen W. Lower AMP-activated protein kinase level is associated with the vulnerability of coronary atherosclerotic plaques by attenuating the expression of monocyte autophagy. Coron Artery Dis 2015; 26: 322-327.
24. Sabe AA, Elmadhun NY, Sadek AA, Chu LM, Bianchi C and Sellke FW. Differential effects of atorvastatin on autophagy in ischemic and nonischemic myocardium in Ossabaw swine with metabolic syndrome. J Thorac Cardiovasc Surg 2014; 148: 3172-3178.
25. Hu XC, Zhang J, Xu BH, Cai L, Ragaz J, Wang ZH, Wang BY, Teng YE, Tong ZS, Pan YY, Yin YM, Wu CP, Jiang ZF, Wang XJ, Lou GY, Liu DG, Feng JF, Luo JF, Sun K, Gu YJ, Wu J and Shao ZM. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG-006): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol 2015; 16: 436-446.
26. Du L, Wei H, Li L, Shan H, Yu Y, Wang Y and Zhang G. Regulation of recombinant Trichinella spiralis 53-kDa protein (rTsP53) on alternatively activated macrophages via STAT6 but not IL-4Ralpha in vitro. Cell Immunol 2014; 288: 1-7.
27. Goodlett CR and Eilers AT. Alcohol-induced Purkinje cell loss with a single binge exposure in neonatal rats: a stereological study of temporal windows of vulnerability. Alcohol Clin Exp Res 1997; 21: 738-744.
28. Fisman EZ, Adler Y and Tenenbaum A. Bio-markers in cardiovascular diabetology: interleukins and matrixins. Adv Cardiol 2008; 45: 44-64.